Cholesterol in patients with coronary heart disease: how low should we go? (Q40368068)

19 September 2017

1 reference

title

Cholesterol in patients with coronary heart disease: how low should we go? (English)

1 reference

19 September 2017

main subject

coronary artery disease

1 reference

H B Rubins

1

1 reference

19 September 2017

publication date

1 August 1995

1 reference

Journal of General Internal Medicine

19 September 2017

published in

1 reference

19 September 2017

volume

10

1 reference

19 September 2017

issue

8

1 reference

19 September 2017

page(s)

464-471

1 reference

Serum cholesterol as a prognostic factor after myocardial infarction: the Framingham Study.

19 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FBF02599922

Regular physical exercise and low-fat diet. Effects on progression of coronary artery disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02599922

Coronary angiographic changes with lovastatin therapy. The Monitored Atherosclerosis Regression Study (MARS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02599922

Effects of intensive multiple risk factor reduction on coronary atherosclerosis and clinical cardiac events in men and women with coronary artery disease. The Stanford Coronary Risk Intervention Project (SCRIP).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02599922

Effects of monotherapy with an HMG-CoA reductase inhibitor on the progression of coronary atherosclerosis as assessed by serial quantitative arteriography. The Canadian Coronary Atherosclerosis Intervention Trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02599922

Effects of therapy with cholestyramine on progression of coronary arteriosclerosis: results of the NHLBI Type II Coronary Intervention Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02599922

Cost and health implications of cholesterol lowering

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02599922

Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.

21 January 2018

1 reference

12 December 2020

Myocardial ischaemia, risk factors and death from coronary heart-disease

1 reference

12 December 2020

Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II)

1 reference

12 December 2020

Practice guidelines, a new reality in medicine. II. Methods of developing guidelines

1 reference

12 December 2020

The value of lowering cholesterol after myocardial infarction

1 reference

12 December 2020

Can lifestyle changes reverse coronary heart disease? The Lifestyle Heart Trial

1 reference

12 December 2020

A receptor-mediated pathway for cholesterol homeostasis

1 reference

12 December 2020

Prognostic importance of cholesterol levels after myocardial infarction

1 reference

12 December 2020

Evaluation of the effectiveness of lipid-lowering therapy (bile acid sequestrants, niacin, psyllium and lovastatin) for treating hypercholesterolemia in veterans

1 reference

12 December 2020

Prevalence of high blood cholesterol among US adults. An update based on guidelines from the second report of the National Cholesterol Education Program Adult Treatment Panel.

1 reference

12 December 2020

Rationale and design of a secondary prevention trial of lowering normal plasma cholesterol levels after acute myocardial infarction: The cholesterol and recurrent events trial (CARE)

1 reference

12 December 2020

Expanded Clinical Evaluation of Lovastatin (EXCEL) study results: two-year efficacy and safety follow-up

1 reference

12 December 2020

The role of risk factors in heart attacks occurring in men with pre-existing ischaemic heart disease

1 reference

12 December 2020

Regression of coronary artery disease as a result of intensive lipid-lowering therapy in men with high levels of apolipoprotein B

1 reference

12 December 2020

Expanded Clinical Evaluation of Lovastatin (EXCEL) study results. I. Efficacy in modifying plasma lipoproteins and adverse event profile in 8245 patients with moderate hypercholesterolemia

1 reference

12 December 2020

Natural history of coronary atherosclerosis using quantitative angiography in men, and implications for clinical trials of coronary regression. The Harvard Atherosclerosis Reversibility Project Study Group

1 reference

12 December 2020

Effect on coronary atherosclerosis of decrease in plasma cholesterol concentrations in normocholesterolaemic patients. Harvard Atherosclerosis Reversibility Project (HARP) Group

1 reference

12 December 2020

Ischaemic heart disease: a secondary prevention trial using clofibrate. Report by a research committee of the Scottish Society of Physicians

1 reference

12 December 2020

Effect of partial ileal bypass surgery on mortality and morbidity from coronary heart disease in patients with hypercholesterolemia. Report of the Program on the Surgical Control of the Hyperlipidemias (POSCH)

1 reference

12 December 2020

Ten-year mortality from cardiovascular disease in relation to cholesterol level among men with and without preexisting cardiovascular disease

1 reference

12 December 2020

Effect of simvastatin on coronary atheroma: the Multicentre Anti-Atheroma Study (MAAS)

1 reference

12 December 2020

Reduction of mortality in the Stockholm Ischaemic Heart Disease Secondary Prevention Study by combined treatment with clofibrate and nicotinic acid

1 reference

12 December 2020

Clofibrate and niacin in coronary heart disease

1 reference

12 December 2020

Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. The Expert Panel

1 reference

12 December 2020

Fifteen year mortality in Coronary Drug Project patients: long-term benefit with niacin

1 reference

12 December 2020

Natural history of myocardial infarction in the coronary drug project: long-term prognostic importance of serum lipid levels. Coronary Drug Project Research Group

1 reference

12 December 2020

Serum lipids and lipoproteins after myocardial infarction: associations with cardiovascular mortality and experience in the Aspirin Myocardial Infarction Study

1 reference

12 December 2020

Beneficial effects of combined colestipol-niacin therapy on coronary atherosclerosis and coronary venous bypass grafts

1 reference

12 December 2020

The quality of care and the quality of measuring it

1 reference

12 December 2020

Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)

1 reference

12 December 2020

Low-fat diet in myocardial infarction: A controlled trial

1 reference

12 December 2020

Serum cholesterol concentration and coronary heart disease in population with low cholesterol concentrations

1 reference

12 December 2020

Effects on coronary artery disease of lipid-lowering diet, or diet plus cholestyramine, in the St Thomas' Atherosclerosis Regression Study (STARS)

1 reference

12 December 2020

Regression of coronary atherosclerosis during treatment of familial hypercholesterolemia with combined drug regimens.

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF02599922

1 reference

Dimensions Publication ID

19 September 2017

1036921502

0 references

1 reference